Epoch Investment Partners Inc. decreased its stake in Hanesbrands Inc. (NYSE:HBI – Free Report) by 4.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 64,250 shares of the textile maker’s stock after selling 3,050 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Hanesbrands were worth $317,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Dimensional Fund Advisors LP boosted its holdings in Hanesbrands by 12.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,749,433 shares of the textile maker’s stock worth $25,642,000 after buying an additional 632,865 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Hanesbrands by 3.5% in the first quarter. Vanguard Group Inc. now owns 40,265,899 shares of the textile maker’s stock worth $233,542,000 after acquiring an additional 1,362,140 shares during the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Hanesbrands during the first quarter worth approximately $1,093,000. Shell Asset Management Co. raised its stake in Hanesbrands by 127.0% in the 1st quarter. Shell Asset Management Co. now owns 20,417 shares of the textile maker’s stock valued at $118,000 after purchasing an additional 11,423 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System lifted its holdings in Hanesbrands by 212.4% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 409,468 shares of the textile maker’s stock valued at $2,375,000 after purchasing an additional 278,383 shares in the last quarter. Hedge funds and other institutional investors own 80.31% of the company’s stock.
Hanesbrands Stock Up 2.4 %
Shares of NYSE HBI opened at $6.86 on Wednesday. The company has a market capitalization of $2.41 billion, a P/E ratio of -114.33 and a beta of 1.57. The company has a debt-to-equity ratio of 50.06, a current ratio of 1.46 and a quick ratio of 0.86. The company has a 50 day simple moving average of $6.14 and a 200-day simple moving average of $5.40. Hanesbrands Inc. has a 1 year low of $3.54 and a 1 year high of $7.06.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on HBI shares. UBS Group upped their target price on shares of Hanesbrands from $5.00 to $6.50 and gave the stock a “neutral” rating in a report on Tuesday, August 27th. Wedbush reissued a “neutral” rating and issued a $5.00 target price on shares of Hanesbrands in a research note on Thursday, June 6th. Stifel Nicolaus upped their price target on Hanesbrands from $4.50 to $6.00 and gave the company a “hold” rating in a research report on Monday, August 12th. Finally, Barclays lifted their price objective on Hanesbrands from $5.00 to $6.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Six investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $5.80.
Read Our Latest Research Report on HBI
Hanesbrands Profile
Hanesbrands Inc, a consumer goods company, designs, manufactures, sources, and sells a range of range of innerwear apparels for men, women, and children in the Americas, Europe, the Asia pacific, and internationally. The company operates through three segments: Innerwear, Activewear, and International.
Further Reading
- Five stocks we like better than Hanesbrands
- Investing in Commodities: What Are They? How to Invest in Them
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Low P/E Ratio and What Does it Tell Investors?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Hanesbrands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanesbrands and related companies with MarketBeat.com's FREE daily email newsletter.